Javascript Menu by Deluxe-Menu.com

Investors / IR News

NEWS

29/03/2010

EU Phase III trial for Juvista is fully recruited

Details of today's press release announcing that the first pivotal Phase III trial for Juvista in scar revision is now fully recruited can be viewed here

PRODUCT PIPELINE
Juvista - Scar Reduction in skin
Adaprev – Scar reduction in tendons
Prevascar - Reduced Scarring
Juvidex - Improved skin appearance
RN1005 - for reduction of scarring
SHARE PRICE

Data supplied by AXL Performance Solutions - http://www.axl.co.uk
ABOUT US | PRODUCTS | RESEARCH & DEVELOPMENT | PARTNERS | MEDIA | INVESTORS | CAREERS | VOLUNTEERS